Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults

Synbiotic Health · with MusB Research · NCT07407894

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 40–75 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
80
US sites recruiting
1
Study start
February 1, 2026
Record last updated
April 22, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.

Being studied: Bifidobacterium adolescentis iVS-1; Placebo

Conditions: Healthy Aging; Anti Aging

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Aged 40-75 years.
  • BMI: 20-34.9 kg/m².
  • Able and willing to sign informed consent and participate for the study duration.

Exclusion Criteria

  • Chronic disease history (liver, kidney, heart).
  • Current pregnancy and/or lactating.
  • Colonoscopy and/or its preparation within 4 weeks of screening.
  • Those who intend to have children during study period.
  • Current probiotic, prebiotics and/or metabolic-altering supplement use.
  • Those who are unable to cooperate with investigators and testing.
  • Known history of cancer and/or ongoing cancer treatments.
  • Abuse of drugs, alcohol, tobacco, nicotine and other substances.
  • History of cardiac diseases: atherosclerosis, heart failure, unstable angina, stable angina, etc., and chronic hypoxic disease: emphysema, pulmonary heart disease and others related.
  • History of chronic and major GI disease (pancreatitis, IBS, and IBD) and intestinal surgeries.
  • Type 1 or 2 diabetes mellitus.
  • Poorly controlled chronic diseases (hypertension, hyperlipidemia) that are clinically unstable.
  • Vulnerable groups, including clinically ill, mentally ill, cognitively impaired, minors, and illiterate etc.
  • Significant weight loss (>20%) in prior one month.
  • Conditions affecting safety or outcome integrity.

Recruiting US locations

  • MusB Research LLC

    New Port Richey, FL 34638

    Site contact: Shalini Jain, PhD · 813-419-0781 · jains@musbresearch.com

Study contacts (from the official record)

  • Shalini Jain, PhD · 813-419-0781 · jains@musbresearch.com
  • Indushekar Manjunatha · imanjunatha@musbresearch.com
All nutrition & metabolism studies in Florida →
iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife… (NCT07407894) | Bored Studies